New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
09:17 EDTOREXOrexigen looking for FDA approval in next few months, says Cowen
Cowen noted Orexigen announced Q4 results last night and provided an update on its regulatory processes. The firm remains positive on Contrave's potential lifecycle management opportunities and reiterates its Outperform rating and $10 price target.
News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
19:16 EDTOREXOn The Fly: After Hours Movers
Subscribe for More Information
14:24 EDTOREXOrexigen says EC grants marketing authorization for Mysimba
Subscribe for More Information
11:38 EDTOREXOrexigen management to meet with Leerink
Meetings to be held in Boston April 1- 2 hosted by Leerink.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use